Biodesix (BDSX) Stock: Buy, Sell, or Hold?
BDSX - Biodesix, Inc. Common Stock
$27.33
-2.50 (-8.38%)
âŧ
5d:
-7.04%
30d:
+9.01%
90d:
+24.28%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 02, 2026
30d
Get Alerted When BDSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BDSX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BDSX is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: BDSX is currently trading at $27.33, which is considered fair relative to its 30-day fair value range of $26.41 to $29.31.
Technical Outlook: Technically, BDSX is showing support break momentum. Immediate support is located at $26.33, while resistance sits at $31.97. Short-term momentum is weak, with the stock down 8.4% recently.
Market Sentiment: BDSX scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.33 (+36.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDSX is showing support break momentum. Immediate support is located at $26.33, while resistance sits at $31.97. Short-term momentum is weak, with the stock down 8.4% recently.
Market Sentiment: BDSX scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.33 (+36.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$26.41 -
$29.31
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.4%)
- BULLISH: Trading 36.6% below Wall St target ($37.33)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$26.41 -
$29.31
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$26.33
Resistance Level
$31.97
Current Trend
Support Break
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.38
Wall Street Target
$37.33
(+36.6%)
Revenue Growth (YoY)
34.2%
Profit Margin
-27.0%
Share & Embed Analysis
Last updated: October 01, 2026 7:39 PM ET
Data refreshes hourly during market hours. Next update: 8:39 PM
Data refreshes hourly during market hours. Next update: 8:39 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDSX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
31 analysts |
$653 | 43 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$231 | 48 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 46 HOLD |
|
LH
Laboratory Corporation oâĻ |
STRONG BUY
20 analysts |
$345 | 65 BUY |
